Safety, Immunogenicity and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People With Diabetes Also Using Insulin Glargine: 12-Month Results From the GEMELLI 1 Trial

Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2020.0008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Switching From Glargine+insulin Aspart to Glargine+insulin Aspart 30 Before Breakfast Combined With Exercise After Dinner and Dividing Meals for the Treatment of Type 2 Diabetes Patients With Poor Glucose Control – A Prospective Cohort Study

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2018English

Use of Short-Acting Insulin Aspart in Managing Older People With Diabetes

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2009English

Faster-Acting Insulin Aspart Provides Faster Onset and Greater Early Exposure vs Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2017English

The Association Between Anti‐insulin Aspart Antibodies and the Pharmacokinetic and Pharmacodynamic Characteristics of Fast‐acting Insulin Aspart in Children and Adolescents With Type 1 Diabetes

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2020English

Insulin Aspart Reduziert Kardiovaskuläre Ereignisse

MMW Fortschritte der Medizin
Medicine
2016English

Insulin Degludec Aspart: The First Co-Formulation of Insulin Analogues

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

The Human Insulin Analog Aspart Can Induce Insulin Allergy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy